Latest Drug Market Insights


Global Orphan Drug Market Outlook 2018
Buy Now

Europe Orphan Drug Market Outlook 2018
Buy Now

US Orphan Drug Market Outlook 2018
Buy Now

Global Orphan Cancer Drug Market & Clinical Pipeline Insight
Buy Now


Buy Now


Buy Now


Buy Now


Buy Now


Buy Now


Buy Now

Read more
All Latest Published Report

Industry News



AveXis Spinal Muscular Atrophy Drug Gets Orphan Drug Status
13-Oct-2014

Navidea Cancer Drug Receives Orphan Drug Designation
12-Oct-2014

Neuroblastoma Vaccine by MabVax Gets Orphan Drug Status
12-Oct-2014

DNAtrixs Gets Orphan Drug Status for Malignant Glioma
10-Oct-2014

Orphan Drug Designation to PEGPH20 by Halozyme
9-Oct-2014

Orphan Drug Status to Actimmune by Horizon Pharma
8-Oct-2014

Aldoxorubicin by CytRx Gets Multiple Orphan Drug Status
29-Sep-2014

NOXXON Pharma Gets Orphan Drug Status For Spiegelmer
25-Sep-2014

Rexahn Pancreatic Cancer Drug Get Orphan Drug Status
23-Sep-2014

Promedior Myelofibrosis Cancer Drug Gets Orphan Drug Status
22-Sep-2014
Read more
 

Email Subscribe

Unsubscribe Here  
Follow us on

KuicK Research 2014   Privacy Policy | Site Map